Sulfonamides and trimethoprim

Cancer Investigation

Volumn 16, Issue 8, 1998, Pages 612-615

  Kalkut, Gary ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE INHIBITOR; FANSIDAR; SULFADIAZINE; SULFADIMIDINE; SULFADOXINE; SULFAFURAZOLE; SULFAMERAZINE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFAMIDOCHRYSOIDINE; SULFONAMIDE; TRIMETHOPRIM;

ALLERGIC REACTION; ANEMIA; ANTIBIOTIC THERAPY; DOSE RESPONSE; DRUG INDICATION; DRUG MECHANISM; FOLIC ACID DEFICIENCY; HEPATITIS; HUMAN; MEGALOBLASTIC ANEMIA; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY DISORDER; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RASH; REVIEW; SALMONELLA; SERUM SICKNESS; THROMBOCYTOPENIA;

EID: 0031741047     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809032892     Document Type: Review

References (24)

1. Pratt WB, Feketey R: The antimetabolites. In: The Antimicrobial Drugs. New York, Oxford University Press, 1986, pp 229-251.
2. Kucers A, Bennett N: Sulfonamides. In: The Use of Antibiotics, 4th ed, Philadelphia, JB Lippincott, 1987, pp 1075-1117.
3. Then RL: Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Clin Infect Dis 4: 261-269, 1982.
4. Zinner SH, Mayer KH: Sulfonamides and trimethoprim. In: Principles and Practice of Infectious Diseases, 4th ed, edited by GL Mandell, JE Bennett, R Dolin. New York, Churchill-Livingstone, 1995, pp 354-364.
5. Reeves D: Sulphonamides and trimethooprim. Lancet 2:370-373, 1982.
6. Lerner PI: Nocardia species. In: Principles and Practice of Infectious Diseases, 4th ed, edited by GL Mandell, JE Bennett, R Dolin, New York, Churchill-Livingstone, 1995, pp 2273-2280.
7. Beamon MH, McCabe RE, Wong SY, Remington JE: Toxoplasma gondii. In: Principles and Practice of Infectious Diseases, 4th ed, edited by GL Mandell, JE Bennett, R Dolin, New York, Churchill-Livingstone, 1995, pp 2455-2475.
8. Abramowicz M: Drugs for parasitic infections. In: The Medical Letter Handbook of Antimicrobial Therapy, New Rochelle, 1998, pp 101-121.
9. Sahai J, Heimberger T, Collins K, et al: Sufadiazine crystalluria in a patients with the acquired immunodeficiency syndrome: a reminder. Am J Med 84: 791-792, 1988.
10. Salter AJ: Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. Clin Infect Dis 4:197-236, 1982.
11. Kucers A, Bennett N: Trimethoprim, co-trimoxazole (Co-t), and other trimethoprim combinations. In: The Use of Antibiotics, 4th ed, Philadelphia, JB Lippincott, 1987, pp 1118-1202.
12. Masur H: Prevention and treatment of pneumocystis pneumonia. N Engl J Med 327:1853-1860, 1992.
13. Gurwith MJ, Brunton JL, Lank BA, et al: A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66:248-256, 1979.
14. Dekker AW, Rozenberg-Arsaka M, Sixma JJ, Verhoef J: Prevention of infection by trimethoprim/sulfamethoxazole plus amphotericin B in patients with acute non-lymphocytic leukemia. Ann Intern Med 95:555-559, 1981.
15. Kaufman CA, Liepman MK, Bergman AG, Mioduszewski J: Trimethoprim/sulfamethaxazole prophylaxis in neutropenic patients. Am J Med 74:599-607, 1983.
16. Gualiteri RJ, Donowitz GR, Kaiser DL, et al: Double-blind study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignacies. Am J Med 74:934-940, 1983.
17. Hughes Wt, Armstrong D, Bodey GP, et al: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161:381-396, 1990.
18. Ward TT, Thomas RG, Fye CL, et al: Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veteran Affairs study. Clin Infect Dis 17:323-332, 1993.
19. Hughes WT: Prevention of infections in patients with T cell defects. Clin Infect Dis 17(Suppl 2):S368-S371, 1993.
20. Bozzette SA, Finklestein DM, Spector SA, et al: A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 332: 693-699, 1995.
21. Hirschtick RE, Glassroth J, Jordan MC, et al: Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 333:845-851, 1995.
22. Carr A, Tindall B, Brew BJ: Low dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 117:106-111, 1992.
23. Absar N, Daneshvar H, Beall G: Desensitization to trimethoprim/ sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol 93:1001-1005, 1994.
24. Sattler FR, Cowan R, Nielson DM, et al: Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective noncrossover study. Ann Intern Med 109:280-287, 1988.